Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,700
Closed -$556K 114
2025
Q4
$556K Buy
1,700
+900
+113% +$285K 0.35% 60
2025
Q3
$226K Buy
+800
New +$232K 0.12% 112
2025
Q2
Sell
-1,900
Closed -$592K 57
2025
Q1
$592K Hold
1,900
0.17% 107
2024
Q4
$495K Sell
1,900
-100
-5% -$29.7K 0.24% 104
2024
Q3
$644K Sell
2,000
-1,500
-43% -$491K 0.22% 65
2024
Q2
$1.09M Buy
3,500
+500
+17% +$147K 0.69% 37
2024
Q1
$853K Sell
3,000
-1,600
-35% -$468K 0.38% 60
2023
Q4
$1.32M Buy
4,600
+1,200
+35% +$327K 0.77% 37
2023
Q3
$914K Buy
+3,400
New +$848K 0.52% 47

Other funds holding AMGN

XY Capital's AMGN Position: Q2 2025 in Review

XY Capital sold out of Amgen (AMGN) in Q2 2025, closing a stake of 581 shares — an estimated $181K sold.

XY Capital first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $221K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • XY Capital reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • XY Capital sold 581 Amgen shares in Q2 2025, an estimated $181K.
  • XY Capital first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • XY Capital's Amgen position peaked at $221K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.